Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018
Shareholder Meeting
Salt Lake City, Utah-- (Globe Newswire- April24, 2018)- Nu-Med Plus, Inc. (OTCBB:
NUMD),a medical device development company announced that April10, 2018
shareholders voted to re-elect all the existing highly qualified directors, Jeffrey
Robins, William Moon, Thomas Tait, Dr. Craig Morrison and Dr. Brett J. Earl, to the
Nu-Med Plus Board of Directors.
Sadler, Gibb and Associates LLCwas also reaffirmed to serve as Nu-Med's
independent registered public accounting firm and auditor.
Jeff Robins, Chairman of the Board and CEO of Nu-Med Plus, Inc remarked, "I greatly
appreciate the strong support from our shareholders and the reaffirmation of their
cont1dence in the Board and our management team by re-electing all 5 of our
incumbent directors. This strong vote of confidence recognizes their hard work and
relentless focus since the inception of our company. We are more energized than
ever about building on NU-MED's strengths to anticipate and deliver our INO
products to the medical community. We plan to maintain an active and productive
dialogue with shareholders as we continue to transform our business and create
value for all of our stakeholders."
About Nu-Med Plus, inc.
Nu-Med Plus, Inc. is a medical device development company created to explore
medical applications of newly developed Nitric Oxide technologies. The emphasis is
to generate controlled-flow of INO for internal therapies with integrating
accessories for availability in hospitals, emergency rooms and urgent care facilities,
medical and chiropractic offices, convalescent and nursing homes, and for
emergency response teams for treatment of various trauma injuries. For more
company information please visit www.nu-medplus.com.
Contact: Keith MerrelljCFO
(801) 746 3570
Forward-Looking Statement"
Information set forth in this news release contains forward-looking statements that are based on assumptions as
ufthe date of this news release. These statements reflect management's current estimates, beliefs, intentions
and expectations. They are not guarantees of future performance. The Company cautions that all forward
looking statements are inherently uncertain and that actual performance may be affected by a number of
material factors, many of which are beyond the Company's control. Such factors include, among other things:
risks and uncertainties relating to the Company'sability to complete proposed private placement financing.
Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs.
intentions and expectations expressed or implied in the forward-looking information. Except as required under
applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward
looking information.
